JPMorgan Chase & Co’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Sell |
|
|||||
|
2025
Q1 | $2.31M | Buy |
|
|||||
|
2024
Q4 | $1.37M | Buy |
|
|||||
|
2024
Q3 | $319K | Buy |
|
|||||
|
2024
Q2 | $153K | Sell |
|
|||||
|
2024
Q1 | $417K | Buy |
|
|||||
|
2023
Q4 | $209K | Buy |
|
|||||
|
2023
Q3 | $205K | Buy |
|
|||||
|
2023
Q2 | $235K | Buy |
|
|||||
|
2023
Q1 | $208K | Sell |
|
|||||
|
2022
Q4 | $1.01M | Buy |
|
|||||
|
2022
Q3 | $1.05M | Buy |
|
|||||
|
2022
Q2 | $317K | Sell |
|
|||||
|
2022
Q1 | $1.59M | Buy |
|
|||||
|
2021
Q4 | $411K | Buy |
|
|||||
|
2021
Q3 | $1.54M | Buy |
|
|||||
|
2021
Q2 | $596K | Buy |
|
|||||
|
2021
Q1 | $506K | Sell |
|
|||||
|
2020
Q4 | $1.63M | Buy |
|